Central Nervous System Drugs Market Global Briefing 2018

Starting Price : $ 1000.00 $ 670.00 | Pages : 35 | Published : January 2018 | SKU CODE : 2767 | Format :

The central nervous system drugs market includes medications that are used in the treatment of diseases affecting the brain or spinal cord. The central nervous system (CNS) integrates sensory information and instructs the body to respond accordingly. The spinal cord is a channel for signals between the brain and the rest of the body. Central nervous system (CNS) disorder is a condition in which the brain and spinal cord’s ability to function is affected, hence affecting the body. The market for CNS disorder drugs comprises of drugs that work in different ways depending on the type of disease by suppressing or boosting the brain activities.

The top five companies covered are Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Pfizer Inc. and Novartis AG. Biogen Idec was the largest company in the central nervous system drugs market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

Central Nervous System Drugs Global Market Size

The global central nervous system drugs market was valued at around $71 billion in 2017. North America was the largest region in the central nervous system drugs market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for nearly 30% market share.

Central Nervous System Drugs Global Market Trend

Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson’s disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%.

Central Nervous System Drugs Global Market Segmentation

The central nervous system drugs market is segmented into Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics Drugs (AED) and Other Central Nervous System Drugs.
Analgesics relieve pain selectively without blocking the conduction of nerve impulses, noticeably changing sensory perception, or affecting consciousness.
Anti-Parkinson Drugs are used to treat symptoms of Parkinson's disease and other forms of Parkinsonism which are caused by the lack of neurotransmitter dopamine in the brain.
Anesthetics cause unconsciousness and unresponsiveness to the body by suppressing responses to sensory stimulation in the brain.
Anti-Epileptics Drugs (AED) also known as anticonvulsants, are preventative drugs used to control epileptic seizures, however they do not cure epilepsy.
Other Central Nervous System Drugs includes Antiemetics, Muscle Relaxants and Sedatives.

Mental Health Software For Keeping Medical Records!
Healthcare Services Now More Efficient And Cost Effective With Digitization!
Family Planning Services Now Available On Mobile Platforms!
Enjoyable Activities In Retirement Communities For Better Customer Satisfaction!
Mergers And Acquisitions In The Veterinary Healthcare Market
Shared Medical Appointments: Balancing Efficiency With Patient Satisfaction
Need A Doctor’s Appointment? Radiology Information System Is At Your Service!
Automation In Air Purification Manufacturing Sector
Blood Glucose Test Strips Global Market Report 2018
View Report
Veterinary Services Global Market Report 2018
View Report
Podiatry Services Global Market Strategies and Opportunities to 2021
View Report
Global Minor Orthopedic Implants Replacement Market, Opportunities And Strategies To 2021
View Report
Global Biologics Market, Opportunities And Strategies To 2021
View Report
Global Pharmaceutical Drugs Market, Opportunities And Strategies To 2021
View Report
Global Diabetes Test Strips Market, Opportunities And Strategies To 2021
View Report
Global Veterinary Services Market, Opportunities And Strategies To 2021
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)